Show simple item record

dc.contributor.authorBroly, M
dc.contributor.authorPolevoda, BV
dc.contributor.authorAwayda, KM
dc.contributor.authorTong, N
dc.contributor.authorLentini, J
dc.contributor.authorBesnard, T
dc.contributor.authorDeb, W
dc.contributor.authorO’Rourke, D
dc.contributor.authorBaptista, Julia
dc.contributor.authorEllard, S
dc.contributor.authorAlmannai, M
dc.contributor.authorHashem, M
dc.contributor.authorAbdulwahab, F
dc.contributor.authorShamseldin, H
dc.contributor.authorAl-Tala, S
dc.contributor.authorAlkuraya, FS
dc.contributor.authorLeon, A
dc.contributor.authorvan Loon, RLE
dc.contributor.authorFerlini, A
dc.contributor.authorSanchini, M
dc.contributor.authorBigoni, S
dc.contributor.authorCiorba, A
dc.contributor.authorvan Bokhoven, H
dc.contributor.authorIqbal, Z
dc.contributor.authorAl-Maawali, A
dc.contributor.authorAl-Murshedi, F
dc.contributor.authorGanesh, A
dc.contributor.authorAl-Mamari, W
dc.contributor.authorLim, SC
dc.contributor.authorPais, LS
dc.contributor.authorBrown, N
dc.contributor.authorRiazuddin, S
dc.contributor.authorBézieau, S
dc.contributor.authorFu, D
dc.contributor.authorIsidor, B
dc.contributor.authorCogné, B
dc.contributor.authorO’Connell, MR
dc.date.accessioned2022-05-03T17:22:21Z
dc.date.issued2022-04
dc.identifier.issn0002-9297
dc.identifier.issn1537-6605
dc.identifier.urihttp://hdl.handle.net/10026.1/19157
dc.description.abstract

Covalent tRNA modifications play multi-faceted roles in tRNA stability, folding, and recognition, as well as the rate and fidelity of translation, and other cellular processes such as growth, development, and stress responses. Mutations in genes that are known to regulate tRNA modifications lead to a wide array of phenotypes and diseases including numerous cognitive and neurodevelopmental disorders, highlighting the critical role of tRNA modification in human disease. One such gene, THUMPD1, is involved in regulating tRNA N4-acetylcytidine modification (ac4C), and recently was proposed as a candidate gene for autosomal-recessive intellectual disability. Here, we present 13 individuals from 8 families who harbor rare loss-of-function variants in THUMPD1. Common phenotypic findings included global developmental delay, speech delay, moderate to severe intellectual deficiency, behavioral abnormalities such as angry outbursts, facial dysmorphism, and ophthalmological abnormalities. We demonstrate that the bi-allelic variants identified cause loss of function of THUMPD1 and that this defect results in a loss of ac4C modification in small RNAs, and of individually purified tRNA-Ser-CGA. We further corroborate this effect by showing a loss of tRNA acetylation in two CRISPR-Cas9-generated THUMPD1 KO cell lines. In addition, we also show the resultant amino acid substitution that occurs in a missense THUMPD1 allele identified in an individual with compound heterozygous variants results in a marked decrease in THUMPD1 stability and RNA-binding capacity. Taken together, these results suggest that the lack of tRNA acetylation due to THUMPD1 loss of function results in a syndromic form of intellectual disability associated with developmental delay, behavioral abnormalities, hearing loss, and facial dysmorphism.

dc.format.extent587-600
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoeng
dc.publisherElsevier BV
dc.subjectN4-acetylcytidine
dc.subjectNAT10
dc.subjectRNA acetylation
dc.subjectTHUMPD1
dc.subjectac4C
dc.subjectdevelopmental disorder
dc.subjectintellectual disability
dc.subjecttRNA biology
dc.subjecttRNA modifications
dc.subjectAcetylation
dc.subjectAlleles
dc.subjectHumans
dc.subjectIntellectual Disability
dc.subjectMutation
dc.subjectNeurodevelopmental Disorders
dc.subjectRNA
dc.subjectRNA, Transfer
dc.subjectRNA-Binding Proteins
dc.titleTHUMPD1 bi-allelic variants cause loss of tRNA acetylation and a syndromic neurodevelopmental disorder
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000789105400005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue4
plymouth.volume109
plymouth.publication-statusPublished
plymouth.journalThe American Journal of Human Genetics
dc.identifier.doi10.1016/j.ajhg.2022.02.001
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2022-02-01
dc.rights.embargodate9999-12-31
dc.identifier.eissn1537-6605
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1016/j.ajhg.2022.02.001
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2022-04-07
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV